Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.
Silverberg JI, Toth D, Bieber T, Alexis AF, Elewski BE, Pink AE, Hijnen D, Jensen TN, Bang B, Olsen CK, Kurbasic A, Weidinger S; ECZTRA 3 study investigators. Silverberg JI, et al. Among authors: weidinger s. Br J Dermatol. 2021 Mar;184(3):450-463. doi: 10.1111/bjd.19573. Epub 2021 Feb 22. Br J Dermatol. 2021. PMID: 33000503 Free PMC article. Clinical Trial.
Genetics of atopic dermatitis.
Bussmann C, Weidinger S, Novak N. Bussmann C, et al. Among authors: weidinger s. J Dtsch Dermatol Ges. 2011 Sep;9(9):670-6. doi: 10.1111/j.1610-0387.2011.07656.x. Epub 2011 Apr 26. J Dtsch Dermatol Ges. 2011. PMID: 21518425 Review. English, German.
Biomarkers for atopic dermatitis: a systematic review and meta-analysis.
Thijs J, Krastev T, Weidinger S, Buckens CF, de Bruin-Weller M, Bruijnzeel-Koomen C, Flohr C, Hijnen D. Thijs J, et al. Among authors: weidinger s. Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):453-60. doi: 10.1097/ACI.0000000000000198. Curr Opin Allergy Clin Immunol. 2015. PMID: 26226355 Review.
Atopic dermatitis.
Weidinger S, Novak N. Weidinger S, et al. Lancet. 2016 Mar 12;387(10023):1109-1122. doi: 10.1016/S0140-6736(15)00149-X. Epub 2015 Sep 13. Lancet. 2016. PMID: 26377142 Review.
Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review.
Barbarot S, Rogers NK, Abuabara K, Aubert H, Chalmers J, Flohr C, Hanifin J, Naldi L, Margolis DJ, Paul C, Ridd MJ, Schuttelaar MA, Simpson E, Tauber M, Volke A, Weidinger S, Wilkes SR, Wollenberg A, Thomas KS. Barbarot S, et al. Among authors: weidinger s. J Am Acad Dermatol. 2016 Nov;75(5):1038-1044. doi: 10.1016/j.jaad.2016.05.043. Epub 2016 Aug 10. J Am Acad Dermatol. 2016. PMID: 27522613 Review.
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
Schmitt J, Abraham S, Trautmann F, Stephan V, Fölster-Holst R, Homey B, Bieber T, Novak N, Sticherling M, Augustin M, Kleinheinz A, Elsner P, Weidinger S, Werfel T. Schmitt J, et al. Among authors: weidinger s. J Dtsch Dermatol Ges. 2017 Jan;15(1):49-59. doi: 10.1111/ddg.12958. Epub 2016 Nov 10. J Dtsch Dermatol Ges. 2017. PMID: 27862987
Atopic dermatitis.
Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Weidinger S, et al. Nat Rev Dis Primers. 2018 Jun 21;4(1):1. doi: 10.1038/s41572-018-0001-z. Nat Rev Dis Primers. 2018. PMID: 29930242 Review.
TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries.
Vermeulen FM, Gerbens LAA, Bosma AL, Apfelbacher CJ, Irvine AD, Arents BWM, Barbarot S, Deleuran M, Eichenfield LF, Manca A, Schmitt J, Vestergaard C, Wall D, Weidinger S, Middelkamp-Hup MA, Spuls PI, Flohr C; International TREAT Registry Taskforce. Vermeulen FM, et al. Among authors: weidinger s. Br J Dermatol. 2019 Sep;181(3):492-504. doi: 10.1111/bjd.17715. Epub 2019 Jun 23. Br J Dermatol. 2019. PMID: 30719709 Free PMC article.
388 results